Although both CHIP and mCAs are known risk factors for hematologic malignancy, CHIP had primarily been associated with myeloid malignancies [15], while mCAs have primarily been associated with lymphoid malignancies [11]. This evidence concerns the gene STUB1 and hematologic disorder.